The prognosis of patients with TDL is difficult to assess because of its multifactorial nature (underlying disease and treatment impact). In our cohort, outcome of MS patients whose first severe DE involved a TDL was better when they received an early immunosuppressive treatment.
Service de neurologie, hôpital Pasteur, 30, voie Romaine, BP 69, 06002 Nice, France. mael0480 [at] yahoo.fr
Rev Neurol (Paris). 2011 Jan;167(1):14-22
© Galenicom 1999-2013